Literature DB >> 25220193

GLP-1 receptor agonists and basal insulin in type 2 diabetes.

Laura A Young1, John B Buse2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25220193     DOI： 10.1016/S0140-6736(14)61409-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

Review 1.  Controlled release of biologics for the treatment of type 2 diabetes.

Authors:  Caslin A Gilroy; Kelli M Luginbuhl; Ashutosh Chilkoti
Journal:  J Control Release       Date:  2015-12-02       Impact factor: 9.776

2.  Type 2 diabetes is associated with impaired jejunal enteroendocrine GLP-1 cell lineage in human obesity.

Authors:  Patricia Serradas; Agnès Ribeiro; Céline Osinski; Léa Le Gléau; Christine Poitou; Juan de Toro-Martin; Laurent Genser; Magali Fradet; Hédi Antoine Soula; Armelle Leturque; Corinne Blugeon; Laurent Jourdren; Edwige Ludiwyne Hubert; Karine Clément
Journal:  Int J Obes (Lond)       Date:  2020-10-09       Impact factor: 5.095
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.